We've found
						8,085
						 archived clinical trials in
						Cervical Cancer
					
				We've found
						8,085
						 archived clinical trials in
						Cervical Cancer
	
	Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
	
Updated: 7/7/2015
  
  
  Cross-Sectional Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
		Status: Enrolling	
	Updated: 7/7/2015
	
	Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
	
Updated: 7/7/2015
  
  
  	  Cross-Sectional Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
		Status: Enrolling	
	Updated: 7/7/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
	
	Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
	
Updated: 7/13/2015
  
  
  	  A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Electronic Patient Reported Symptom Assessment
	
Updated: 7/13/2015
  
  
  Electronic Patient Reported Symptom Assessment: A Pilot Study Introducing Advanced Care Planning and Palliative Care to Hospitalized Women With Advanced Gynecologic, Breast, Thoracic, or Gastrointestinal Malignancies.
		Status: Enrolling	
	Updated: 7/13/2015
	
	Electronic Patient Reported Symptom Assessment
	
Updated: 7/13/2015
  
  
  	  Electronic Patient Reported Symptom Assessment: A Pilot Study Introducing Advanced Care Planning and Palliative Care to Hospitalized Women With Advanced Gynecologic, Breast, Thoracic, or Gastrointestinal Malignancies.
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
		    
			
	Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
	
Updated: 7/17/2015
  
  
  Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
		Status: Enrolling	
	Updated: 7/17/2015
	
	Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
	
Updated: 7/17/2015
  
  
  	  Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
		Status: Enrolling	
	Updated: 7/17/2015
Click here to add this to my saved trials
		    
			
	Breast and Cervical Cancer Educational Intervention for Latinas in Western New York
	
Updated: 7/21/2015
  
  
  Investigating a Breast and Cervical Cancer Intervention for Latinas in Western New York
		Status: Enrolling	
	Updated: 7/21/2015
	
	Breast and Cervical Cancer Educational Intervention for Latinas in Western New York
	
Updated: 7/21/2015
  
  
  	  Investigating a Breast and Cervical Cancer Intervention for Latinas in Western New York
		Status: Enrolling	
	Updated: 7/21/2015
Click here to add this to my saved trials
		    
			
	Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
	
Updated: 7/25/2015
  
  
  A Phase II Study of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
		Status: Enrolling	
	Updated: 7/25/2015
	
	Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
	
Updated: 7/25/2015
  
  
  	  A Phase II Study of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
		Status: Enrolling	
	Updated: 7/25/2015
Click here to add this to my saved trials
		    
			
	Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
	
Updated: 8/3/2015
  
  
  A Phase 1 Study of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Body Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer
		Status: Enrolling	
	Updated: 8/3/2015
	
	Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
	
Updated: 8/3/2015
  
  
  	  A Phase 1 Study of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Body Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer
		Status: Enrolling	
	Updated: 8/3/2015
Click here to add this to my saved trials
		    
			
	Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
	
Updated: 8/3/2015
  
  
  Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
		Status: Enrolling	
	Updated: 8/3/2015
	
	Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
	
Updated: 8/3/2015
  
  
  	  Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
		Status: Enrolling	
	Updated: 8/3/2015
Click here to add this to my saved trials
		    
			
	Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
	
Updated: 8/3/2015
  
  
  Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
		Status: Enrolling	
	Updated: 8/3/2015
	
	Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
	
Updated: 8/3/2015
  
  
  	  Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
		Status: Enrolling	
	Updated: 8/3/2015
Click here to add this to my saved trials
		    
			
	Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
	
Updated: 8/3/2015
  
  
  Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
		Status: Enrolling	
	Updated: 8/3/2015
	
	Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
	
Updated: 8/3/2015
  
  
  	  Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
		Status: Enrolling	
	Updated: 8/3/2015
Click here to add this to my saved trials
		    
			
	Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
	
Updated: 8/3/2015
  
  
  Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
		Status: Enrolling	
	Updated: 8/3/2015
	
	Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
	
Updated: 8/3/2015
  
  
  	  Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
		Status: Enrolling	
	Updated: 8/3/2015
Click here to add this to my saved trials
		    
			
	Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
	
Updated: 8/3/2015
  
  
  Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
		Status: Enrolling	
	Updated: 8/3/2015
	
	Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
	
Updated: 8/3/2015
  
  
  	  Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
		Status: Enrolling	
	Updated: 8/3/2015
Click here to add this to my saved trials
		    
			
	Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
	
Updated: 8/10/2015
  
  
  Randomized Phase II Study of Zoledronic Acid vs Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
		Status: Enrolling	
	Updated: 8/10/2015
	
	Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
	
Updated: 8/10/2015
  
  
  	  Randomized Phase II Study of Zoledronic Acid vs Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
		Status: Enrolling	
	Updated: 8/10/2015
Click here to add this to my saved trials
		    
			
	Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
	
Updated: 8/14/2015
  
  
  Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
		Status: Enrolling	
	Updated: 8/14/2015
	
	Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
	
Updated: 8/14/2015
  
  
  	  Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
		Status: Enrolling	
	Updated: 8/14/2015
Click here to add this to my saved trials
		    
			
	Bupropion in Helping Adults Stop Smoking
	
Updated: 8/27/2015
  
  
  A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
		Status: Enrolling	
	Updated: 8/27/2015
	
	Bupropion in Helping Adults Stop Smoking
	
Updated: 8/27/2015
  
  
  	  A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
		Status: Enrolling	
	Updated: 8/27/2015
Click here to add this to my saved trials
		    
			
	Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
	
Updated: 8/31/2015
  
  
  Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
		Status: Enrolling	
	Updated: 8/31/2015
	
	Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
	
Updated: 8/31/2015
  
  
  	  Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
		Status: Enrolling	
	Updated: 8/31/2015
Click here to add this to my saved trials
		    
			
	Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
	
Updated: 8/31/2015
  
  
  Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
		Status: Enrolling	
	Updated: 8/31/2015
	
	Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
	
Updated: 8/31/2015
  
  
  	  Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
		Status: Enrolling	
	Updated: 8/31/2015
Click here to add this to my saved trials
		    
			
	Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
	
Updated: 8/31/2015
  
  
  Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
		Status: Enrolling	
	Updated: 8/31/2015
	
	Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
	
Updated: 8/31/2015
  
  
  	  Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
		Status: Enrolling	
	Updated: 8/31/2015
Click here to add this to my saved trials
		    
			
	Magnetic Resonance Elastography (MRE) of Uterine Fibroids
	
Updated: 9/1/2015
  
  
  Magnetic Resonance Elastography (MRE) of Uterine Fibroids
		Status: Enrolling	
	Updated: 9/1/2015
	
	Magnetic Resonance Elastography (MRE) of Uterine Fibroids
	
Updated: 9/1/2015
  
  
  	  Magnetic Resonance Elastography (MRE) of Uterine Fibroids
		Status: Enrolling	
	Updated: 9/1/2015
Click here to add this to my saved trials